Comparison of Extubation Delay After Prolonged Sedation (ISOREA)
Comparison of Extubation Delay After Prolonged Sedation With Inhaled Isoflurane Using the MIRUS® Device or Continuous Intravenous Midazolam in Patients With Septic Shock in Intensive Care
Sponsor: University Hospital, Rouen
Terminated
COVID epidemic and sedation practices that have completely changed: the standard sedative is now propofol rather than midazolam.
Listed as NCT04710914, this PHASE4 trial focuses on Septic Shock and remains terminated or withdrawn. Sponsored by University Hospital, Rouen, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Feb 2026 — Present [monthly]
Terminated PHASE4
Status: Unknown → Terminated
-
Sep 2024 — Feb 2026 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
May 2023 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Feb 2021 — May 2023 [monthly]
Recruiting PHASE4
First recorded
Dec 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Rouen
For direct contact, visit the study record on ClinicalTrials.gov .